Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 03 03:08PM ET
126.22
Dollar change
-1.73
Percentage change
-1.35
%
Index- P/E104.85 EPS (ttm)1.20 Insider Own6.91% Shs Outstand95.49M Perf Week10.09%
Market Cap12.06B Forward P/E11.40 EPS next Y11.08 Insider Trans-0.31% Shs Float88.92M Perf Month2.38%
Income121.84M PEG- EPS next Q1.54 Inst Own89.86% Short Float5.67% Perf Quarter-6.36%
Sales1.64B P/S7.35 EPS this Y138.13% Inst Trans-2.29% Short Ratio5.15 Perf Half Y5.43%
Book/sh12.79 P/B9.87 EPS next Y400.84% ROA3.63% Short Interest5.04M Perf Year49.48%
Cash/sh12.55 P/C10.06 EPS next 5Y- ROE12.27% 52W Range83.97 - 173.25 Perf YTD30.89%
Dividend Est.- P/FCF- EPS past 5Y-1.21% ROI4.82% 52W High-27.15% Beta0.75
Dividend TTM- Quick Ratio3.03 Sales past 5Y32.89% Gross Margin83.56% 52W Low50.32% ATR (14)5.35
Dividend Ex-Date- Current Ratio3.84 EPS Y/Y TTM116.50% Oper. Margin4.94% RSI (14)54.96 Volatility6.24% 4.80%
Employees1314 Debt/Eq1.14 Sales Y/Y TTM48.45% Profit Margin7.43% Recom1.36 Target Price185.20
Option/ShortYes / Yes LT Debt/Eq1.07 EPS Q/Q173.55% Payout- Rel Volume0.42 Prev Close127.95
Sales Surprise14.74% EPS Surprise670.47% Sales Q/Q40.79% EarningsNov 06 AMC Avg Volume979.21K Price126.22
SMA206.48% SMA503.18% SMA200-2.95% Trades Volume359,626 Change-1.35%
Date Action Analyst Rating Change Price Target Change
Nov-27-24Reiterated Needham Buy $205 → $202
Nov-25-24Initiated H.C. Wainwright Sell $80
Nov-07-24Upgrade Cantor Fitzgerald Neutral → Overweight $152 → $167
Oct-21-24Initiated Jefferies Buy $165
Oct-10-24Resumed Raymond James Outperform $150
Jul-29-24Upgrade RBC Capital Mkts Sector Perform → Outperform $182
Jun-26-24Downgrade Citigroup Buy → Neutral $172 → $176
May-31-24Initiated Piper Sandler Overweight $157
May-28-24Downgrade RBC Capital Mkts Outperform → Sector Perform $157 → $142
May-14-24Upgrade Oppenheimer Perform → Outperform $180
Nov-30-24 06:00AM
Nov-29-24 04:10PM
Nov-28-24 08:15AM
Nov-27-24 09:55AM
07:21AM
07:20AM Loading…
07:20AM
06:00AM
04:33AM
Nov-26-24 05:18PM
04:05PM
09:06AM
07:00AM
07:00AM
Nov-15-24 12:26PM
Nov-12-24 06:56AM
06:57AM Loading…
Nov-08-24 06:57AM
Nov-07-24 06:01AM
04:00AM
02:20AM
Nov-06-24 06:30PM
04:22PM
04:05PM
Oct-31-24 04:10PM
Oct-27-24 09:07AM
Oct-23-24 08:30AM
Oct-18-24 08:00AM
Oct-17-24 09:53AM
Oct-16-24 04:02PM
Oct-03-24 08:15AM
Sep-30-24 04:39PM
12:38PM Loading…
12:38PM
Sep-26-24 08:30AM
Sep-21-24 10:10AM
Sep-19-24 08:30AM
Sep-16-24 08:30AM
Sep-14-24 07:27PM
Sep-13-24 06:45AM
Sep-08-24 02:00AM
Sep-06-24 11:31AM
Sep-05-24 09:00AM
Sep-03-24 12:37PM
Aug-30-24 04:10PM
08:53AM
08:30AM
Aug-20-24 02:30PM
Aug-19-24 07:00AM
Aug-12-24 09:30AM
Aug-09-24 04:17PM
09:35AM
Aug-08-24 01:36PM
07:50AM
12:30AM
Aug-07-24 06:00PM
04:28PM
04:17PM
04:05PM
Aug-05-24 12:00PM
Aug-01-24 10:01AM
Jul-31-24 04:15PM
Jul-29-24 07:00AM
Jul-21-24 06:59AM
Jul-19-24 09:55AM
Jul-17-24 08:00AM
Jul-16-24 12:00PM
Jul-08-24 12:04PM
Jul-06-24 08:00AM
Jul-04-24 06:35AM
Jul-03-24 10:05AM
Jun-28-24 06:30PM
Jun-26-24 10:06AM
03:45AM
Jun-24-24 02:55PM
03:49AM
Jun-21-24 05:25PM
05:05PM
04:28PM
04:23PM
02:39PM
01:53PM
01:00PM
12:58PM
12:48PM
12:29PM
12:14PM
11:24AM
11:09AM
11:00AM
10:42AM
09:32AM
09:31AM
09:14AM
08:42AM
07:52AM
07:34AM
06:40AM
Jun-20-24 05:02PM
02:13PM
01:22PM
Jun-13-24 04:04PM
01:07PM
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Estepan Ian MichaelChief Financial OfficerAug 30 '24Sale137.365,985822,10033,946Sep 03 08:00 PM
Estepan Ian MichaelOfficerAug 30 '24Proposed Sale137.375,985822,130Aug 30 05:03 PM
Chambers Michael AndrewDirectorAug 16 '24Buy133.8037,0384,955,728284,034Aug 20 08:00 AM
BEHRENS M KATHLEENDirectorJul 03 '24Option Exercise13.9015,000208,500191,839Jul 08 08:00 PM
Brown Ryan EdwardEVP, General CounselJun 25 '24Option Exercise62.7723,5001,475,09556,086Jun 25 08:00 PM
Brown Ryan EdwardEVP, General CounselJun 25 '24Sale161.6138,9576,296,02917,129Jun 25 08:00 PM
Arif BilalChief Tech Ops OfficerJun 24 '24Sale163.087,8591,281,62121,261Jun 25 08:00 PM
Arif BilalChief Tech Ops OfficerJun 25 '24Sale163.233,898636,27117,363Jun 25 08:00 PM
Murray DallanChief Customer OfficerMay 02 '24Sale140.003,635508,90018,125May 06 08:09 PM
Wigzell Hans Lennart RudolfDirectorMar 08 '24Option Exercise13.9015,000208,50037,840Mar 11 08:02 PM
Wigzell Hans Lennart RudolfDirectorMar 08 '24Sale123.2515,0001,848,79522,840Mar 11 08:02 PM
Boor Kathryn JeanDirectorMar 11 '24Sale122.9376193,5507,516Mar 11 08:00 PM
Mayo StephenDirectorMar 05 '24Sale122.963,135385,4806,621Mar 06 08:00 PM
Arif BilalChief Tech Ops OfficerMar 01 '24Sale128.842,000257,67626,836Mar 05 08:00 PM
Estepan Ian MichaelChief Financial OfficerMar 01 '24Sale128.301,200153,96039,114Mar 05 08:00 PM
Brown Ryan EdwardEVP, General CounselMar 01 '24Sale125.342,000250,68031,827Mar 05 08:00 PM